It has only been modified to comply with this publication’s space and style. Honeywell and SGP BioEnergy announced they are ...

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products ...

Sales decline 13.63% to Rs 12.86 crore. Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September 2024 as against net loss of Rs 3.57 cr ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Krebs Biochemicals & Industries Ltd share price was up by 2.06% from the previous closing price of ₹90.64. Who are peers of Krebs Biochemicals & Industries Ltd? The peers of Krebs Biochemicals ...

Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments ...

Krebs Biochemicals & Industries Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 189.80 Crore) operating in Pharmaceuticals sector. Krebs Biochemicals & ...

Here is a breakdown of the information Aemetis Inc presented to its investors. Aemetis Inc., headquartered in Cupertino, California, is a renewable natural gas, renewable fuels, and biochemicals ...

The ingredient solutions segment focuses on supplying food preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, and other industries, and also biochemicals ...

Arsenal news as Mathieu Flamini continues his impressive business venture away from football after retiring in 2019 ...

Mathieu Flamini became a fan favourite at Arsenal during his two spells at the club and the midfielder has not ruled out the ...

Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...